kras mutation and glutathion glynac G12 mutant alleles differentially control glutamine metabolism via FOXO1 Targeting KRAS: from metabolic regulation
Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



